Results 21 to 30 of about 15,511 (270)

Implementing long-acting injectable HIV pre-exposure prophylaxis services at private pharmacies in Kenya: client, pharmacy provider and key stakeholder perspectives on potential challenges and opportunities [PDF]

BMJ Global Health
Introduction Maximising the impact of new and forthcoming long-acting injectable HIV pre-exposure prophylaxis (PrEP) products will require novel delivery approaches that widen accessibility and prioritise clients’ needs and preferences. To understand the
Katrina F Ortblad, Jenell Stewart, Kenneth Ngure, Elizabeth A Bukusi, Stephanie D Roche, Nicholas Thuo, Maurice Opiyo, Marion Hewa, Alfred Odira, Vallery Ogello, Kevin Kamolloh, Emmah Owidi, Perez Ochwal, Lydia Adiema, Felix Mogaka, Victor O Omollo, Rachel C Malen, Kendall Harkey   +17 more
doaj   +2 more sources

Continuation of subcutaneous or intramuscular injectable contraception when administered by facility-based and community health workers: findings from a prospective cohort study in Burkina Faso and Uganda. [PDF]

Contraception, 2018
MacLachlan E, Atuyambe LM, Millogo T, Guiella G, Yaro S, Kasasa S, Bukenya J, Nyabigambo A, Mubiru F, Tumusiime J, Onadja Y, Zan LM, Goeum/Sanon C, Kouanda S, Namagembe A.   +14 more
europepmc   +3 more sources

Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries. [PDF]

Glob Health Sci Pract, 2018
Stout A, Wood S, Barigye G, Kaboré A, Siddo D, Ndione I.   +5 more
europepmc   +3 more sources

Behavioral Drivers Influencing Women's Decision to Use Self-Injectable Contraception Provided by Community Health Surveillance Assistants in Rural Malawi. [PDF]

Womens Health Rep (New Rochelle)
Kamanga M, Walker D, Malata A, Nyando M, Salamba J, Nkhoma A, Mtalimanja I, Jumbe T, Potolani E, Maluwa A, Zimba C, Changole J, Bika R, Himes E, Suchman L, Vallin J, Phillips B, Liu J, Holt K.   +18 more
europepmc   +2 more sources

Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort study

Lancet HIV,the, 2015
Lisa Noguchi, Barbra A. Richardson, Jared M. Baeten, Sharon L. Hillier, Jennifer E. Balkus, Zvavahera M. Chirenje, Katherine Bunge, Gita Ramjee, Gonasagrie Nair, Thesla Palanee‐Phillips, Pearl Selepe, Ariane van der Straten, Urvi M. Parikh, Kailazarid Gomez, Jeanna Piper, D. Heather Watts, Jeanne Marrazzo   +16 more
openalex   +4 more sources

Short-Term Use of Injectable Contraception: An Effective Strategy for Safe Motherhood. [PDF]

J Obstet Gynaecol India, 2018
Khadilkar SS.
europepmc   +3 more sources

Serum norethisterone (NET) levels in NET-enanthate (NET-EN) injectable contraception users substantially interfere with testosterone immunoassay measurements and confound interpretation of biological outcomes. [PDF]

Contracept Reprod Med
Avenant C, Moliki JM, Bick AJ, Dlamini S, Singata-Madliki M, Hofmeyr GJ, Chen PL, Storbeck KH, Africander DJ, Erikson DW, Hapgood JP.   +10 more
europepmc   +3 more sources

DESCRIPTION OF MENSTRUAL CYCLE DISORDERS IN 3 MONTHS INJECTABLE CONTRACEPTIVE USERS

Journal of Vocational Nursing, 2021
Introduction: Injectable contraception (3-month) is a hormonal contraceptive that is widely used by women of childbearing age because it is very effective in preventing pregnancy, and includes the Intermediate- term Method.
Amellia Mardhika, Yolanda Dwi Safitri, Lailatul Fadliyah, Riris Medawati   +3 more
doaj   +1 more source

Combination injectable contraceptives for contraception [PDF]

Cochrane Database of Systematic Reviews, 2005
Combination injectable contraceptives provide a highly effective, reversible method of preventing pregnancy, and they do not require daily administration or use at the time of coitus. Although they are used in many countries, their acceptability could be limited by method characteristics, such as the need to obtain a monthly injection or bleeding ...
M F, Gallo, D A, Grimes, K F, Schulz, C, d'Arcangues, L M, Lopez   +4 more
openaire   +4 more sources

Potential for cost recovery: women's willingness to pay for injectable contraceptives in Tigray, Ethiopia. [PDF]

, 2013
ObjectiveTo investigate factors associated with a woman's willingness to pay (WTP) for injectable contraceptives in Tigray, Ethiopia.MethodsWe used a multistage random sampling design to generate a representative sample of reproductive age women from the
Bell, Suzanne, Gessessew, Amanuel, Prata, Ndola, Weidert, Karen   +3 more
core   +6 more sources